SCHEMBL6211802

SCHEMBL6211802

CCCNC(=O)OSc1cccnc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.44
RAB9A P51151 3/20 0.42
FAAH O00519 2/20 0.42
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GAA P10253 2/20 0.40
HDAC3 O15379 2/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PKM P14618 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6208983 0.80 HTT (0.53) SMN1; SMN2GAAHDAC1KMT2ACYP1A2
SCHEMBL6210380 0.78 ALDH1A1 (0.41) RAB9AALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL27699463 0.76 ALDH1A1 (0.43) RAB9AALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL6208526 0.75 HPGD (0.40) RAB9AALDH1A1KMT2AMEN1L3MBTL1
SCHEMBL28198363 0.74 ALDH1A1 (0.46) RAB9AALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL12933660 0.73 FAAH (0.70) RAB9AFAAHALDH1A1SMN1; SMN2HDAC3
SCHEMBL2497123 0.70 THRB (0.68) RAB9AALDH1A1NPC1SMN1; SMN2GAA
SCHEMBL10987238 0.68 CDK2 (0.75) RAB9AALDH1A1NPC1SMN1; SMN2KMT2A
SCHEMBL27802853 0.68 FAAH (0.67) FAAHKMT2A
SCHEMBL6211869 0.67 FAAH (0.66) FAAHKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608662-A1 GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2005-12-28 EP claimed
WO-2004083218-A1 GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2004-09-30 WO claimed
EP-1608662-A1 GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2005-12-28 EP disclosed
WO-2004083218-A1 GUANIDINE DERIVATIVES AND USE THEREOF AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2004-09-30 WO disclosed